A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients

The combination of irinotecan (CPT-11), oxaliplatin (L-OHP), 5-fluorouracil (5-FU) and folinic acid (FA) is one of the possibilities to overcome chemoresistance in advanced colorectal cancer (ACRC) patients. The aim of this study was to determine the tolerability and activity of CPT-11 plus chronomo...

Descripción completa

Detalles Bibliográficos
Autores principales: Garufi, C, Bria, E, Vanni, B, Zappalà, A M R, Sperduti, I, Terzoli, E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394458/
https://www.ncbi.nlm.nih.gov/pubmed/14612895
http://dx.doi.org/10.1038/sj.bjc.6601382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394458/
https://www.ncbi.nlm.nih.gov/pubmed/14612895
http://dx.doi.org/10.1038/sj.bjc.6601382

Ejemplares similares